We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.27%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$2.42B
AUM Growth
-$119M
(-4.7%)
Cap. Flow
-$116M
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
11.89%
Holding
424
New
35
Increased
125
Reduced
216
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$22.3M |
| 2 |
AES
AES
|
+$14M |
| 3 |
SNV
Synovus
SNV
|
+$13.3M |
| 4 |
Delta Air Lines
DAL
|
+$12.8M |
| 5 |
Albemarle
ALB
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$21.4M |
| 2 |
Cisco
CSCO
|
+$18.9M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.4M |
| 4 |
HP
HPQ
|
+$13.9M |
| 5 |
GSK
GSK
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.35% |
| 2 | Industrials | 15.2% |
| 3 | Technology | 9.4% |
| 4 | Healthcare | 8.25% |
| 5 | Consumer Discretionary | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Entravision Communication
EVC
$969M
| $2.86M | 0.12% |
+899,813
| New | +$2.83M |
|
227
Bassett Furniture
BSET
$167M
| $2.85M | 0.12% |
+186,312
| New | +$2.46M |
|
228
American Public Education
APEI
$884M
| $2.84M | 0.12% |
+127,240
| New | +$3.49M |
|
229
Neogen
NEOG
$2.09B
| $2.81M | 0.12% |
82,622
-586
| -0.7% | -$20.3K |
|
230
First Bancorp
FNLC
$383M
| $2.62M | 0.11% |
95,395
-5,650
| -6% | -$146K |
|
|
USAP
231
DELISTED
Universal Stainless & Alloy
USAP
| $2.62M | 0.11% |
167,908
-8,712
| -5% | -$138K |
|
232
Emergent Biosolutions
EBS
$387M
| $2.62M | 0.11% |
50,034
-489
| -1% | -$22.8K |
|
233
Omnicell
OMCL
$1.81B
| $2.54M | 0.1% |
35,160
-82
| -0.2% | -$6.02K |
|
|
RP
234
DELISTED
RealPage, Inc.
RP
| $2.54M | 0.1% |
40,354
-94
| -0.2% | -$5.89K |
|
|
JBTM
235
JBT Marel
JBTM
$6.99B
| $2.46M | 0.1% |
24,776
-181
| -0.7% | -$19.9K |
|
236
Encompass Health
EHC
$11B
| $2.44M | 0.1% |
48,544
-329
| -0.7% | -$16.5K |
|
237
Bar Harbor Bankshares
BHB
$640M
| $2.44M | 0.1% |
97,704
-6,040
| -6% | -$144K |
|
238
Otter Tail
OTTR
$3.87B
| $2.43M | 0.1% |
45,234
+35,774
| +378% | +$1.87M |
|
239
Silicon Laboratories
SLAB
$7.15B
| $2.41M | 0.1% |
21,604
+6,479
| +43% | +$701K |
|
240
Cavco Industries
CVCO
$4.33B
| $2.4M | 0.1% |
12,511
-153
| -1% | -$27.1K |
|
241
Blackbaud
BLKB
$1.44B
| $2.38M | 0.1% |
26,330
+3,296
| +14% | +$293K |
|
242
Lifecore Biomedical
LFCR
$166M
| $2.37M | 0.1% |
217,895
-13,050
| -6% | -$142K |
|
243
AXT Inc
AXTI
$3.46B
| $2.37M | 0.1% |
664,395
+68,500
| +11% | +$264K |
|
244
Euronet Worldwide
EEFT
$2.94B
| $2.36M | 0.1% |
16,111
-33
| -0.2% | -$5.11K |
|
|
SUM
245
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.36M | 0.1% |
107,945
-239
| -0.2% | -$4.72K |
|
|
ESSA
246
DELISTED
ESSA Bancorp
ESSA
| $2.31M | 0.1% |
140,520
-8,875
| -6% | -$136K |
|
247
Tyler Technologies
TYL
$11.9B
| $2.31M | 0.1% |
8,782
-20
| -0.2% | -$4.9K |
|
248
Hooker Furnishings Corp
HOFT
$143M
| $2.29M | 0.09% |
107,017
+17,594
| +20% | +$354K |
|
249
Hexcel
HXL
$8.29B
| $2.19M | 0.09% |
26,702
-57
| -0.2% | -$4.66K |
|
250
Chefs' Warehouse
CHEF
$3.85B
| $2.19M | 0.09% |
54,292
-361
| -0.7% | -$13.5K |
|
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Foundry Partners held 424 positions worth $2.42B, down 4.7% from $2.54B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Foundry Partners withdrew a net $116M in Q3 2019, closing 37 positions and reducing 216 holdings. Its most notable exit was Allergan plc, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.
Against the trend, Foundry Partners opened a new position in Altria Group worth $19.8M.
- Foundry Partners's largest Q3 2019 buy was Altria Group: 484,800 shares worth $19.8M.
- Foundry Partners added most to Gilead Sciences in Q3 2019, an estimated $11.6M increase.
- Foundry Partners's biggest Q3 2019 reduction was Cisco, cutting an estimated $18.9M.
- Foundry Partners fully exited Allergan plc in Q3 2019, selling an estimated $21.4M.
- Foundry Partners's ten largest holdings make up 12% of its $2.42B portfolio in Q3 2019.
- Foundry Partners opened 35 new positions and closed 37 in Q3 2019.
- Foundry Partners's portfolio value fell 4.7% quarter-over-quarter to $2.42B.
Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.